Global Lichen Sclerosus Treatment Market Size, Share, Forecast Report, 2020-2027

Lichen sclerosus is a skin disease that affects the genital and anal areas. In some cases, they may appear on upper body such as arms and breast regions. The main cause of lichen sclerosus is still unknown, but some of the other causes are hormonal imbalance, hyper immunity reactions. Patients with skin destruction around genital or anal region are more susceptible to develop lichen sclerosus. Generally women suffering from vulva’s lichen sclerosus are at a high risk of developing vulvar cancer.

Increasing prevalence of skin diseases worldwide is one of the major factors contributing to the growth of the market. Moreover, hormonal misbalance in females undergoing menopause are more susceptible to lichen sclerosus, which boosts the growth of market.

On the other hand, availability of exact treatment, and unawareness about rare skin diseases among people may hamper the market growth.

The global lichen sclerosus treatment market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to reach USD 150 million by 2023.
Key Players in the Global Lichen Sclerosus Treatment Market

Some of the key players in this market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.

Segments
The global sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy and surgery. The drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. Surgery is further segmented into laser surgery, circumcision, and others.

On the basis of mode of administration, the market is segmented into oral, topical, IV (Intravenous), and others. Oral is further segmented into tablets, capsule, and others. The topical administration is further segmented into creams, ointment, and others.

On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.